Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: Clinical and functional characterization of two novel ABCC8 mutations

Flavio Faletra, Kara Snider, Show-Ling Shyng, Irene Bruno, Emmanouil Athanasakis, Paolo Gasparini, Carlo Dionisi-Vici, Alessandro Ventura, Qing Zhou, Charles A. Stanley, Alberto Burlina

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Congenital hyperinsulinism (CHI) occurs as a consequence of unregulated insulin secretion from the pancreatic beta-cells. Severe recessive mutations and milder dominant mutations have been described in the ABCC8 and KCNJ11 genes encoding SUR1 and Kir6.2 subunits of the beta-cell ATP-sensitive K(+) channel. Here we report two patients with CHI unresponsive to medical therapy with diazoxide. Sequencing analysis identified a compound heterozygous mutation in ABCC8 in both patients. The first one is a carrier for the known mild dominant mutation p.Glu1506Lys jointly with the novel mutation p.Glu1323Lys. The second carries the p.Glu1323Lys mutation and a second novel mutation, p.Met1394Arg. Functional studies of both novel alleles showed reduced or null cell surface expression, typical of recessive mutations. Compound heterozygous mutations in congenital hyperinsulinism result in complex interactions. Studying these mechanisms can improve the knowledge of this disease and modify its therapy.

Original languageEnglish (US)
Pages (from-to)122-125
Number of pages4
JournalGene
Volume516
Issue number1
DOIs
StatePublished - Mar 1 2013

Fingerprint

Congenital Hyperinsulinism
Mutation
Diazoxide
Null Lymphocytes
Insulin-Secreting Cells
Adenosine Triphosphate
Alleles
Insulin

Keywords

  • ABCC8
  • Congenital hyperinsulinism
  • Functional study
  • Mutation

ASJC Scopus subject areas

  • Genetics

Cite this

Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism : Clinical and functional characterization of two novel ABCC8 mutations. / Faletra, Flavio; Snider, Kara; Shyng, Show-Ling; Bruno, Irene; Athanasakis, Emmanouil; Gasparini, Paolo; Dionisi-Vici, Carlo; Ventura, Alessandro; Zhou, Qing; Stanley, Charles A.; Burlina, Alberto.

In: Gene, Vol. 516, No. 1, 01.03.2013, p. 122-125.

Research output: Contribution to journalArticle

Faletra, F, Snider, K, Shyng, S-L, Bruno, I, Athanasakis, E, Gasparini, P, Dionisi-Vici, C, Ventura, A, Zhou, Q, Stanley, CA & Burlina, A 2013, 'Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: Clinical and functional characterization of two novel ABCC8 mutations', Gene, vol. 516, no. 1, pp. 122-125. https://doi.org/10.1016/j.gene.2012.12.055
Faletra, Flavio ; Snider, Kara ; Shyng, Show-Ling ; Bruno, Irene ; Athanasakis, Emmanouil ; Gasparini, Paolo ; Dionisi-Vici, Carlo ; Ventura, Alessandro ; Zhou, Qing ; Stanley, Charles A. ; Burlina, Alberto. / Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism : Clinical and functional characterization of two novel ABCC8 mutations. In: Gene. 2013 ; Vol. 516, No. 1. pp. 122-125.
@article{2827f6e1fd324833a1d4097c1b9ad764,
title = "Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: Clinical and functional characterization of two novel ABCC8 mutations",
abstract = "Congenital hyperinsulinism (CHI) occurs as a consequence of unregulated insulin secretion from the pancreatic beta-cells. Severe recessive mutations and milder dominant mutations have been described in the ABCC8 and KCNJ11 genes encoding SUR1 and Kir6.2 subunits of the beta-cell ATP-sensitive K(+) channel. Here we report two patients with CHI unresponsive to medical therapy with diazoxide. Sequencing analysis identified a compound heterozygous mutation in ABCC8 in both patients. The first one is a carrier for the known mild dominant mutation p.Glu1506Lys jointly with the novel mutation p.Glu1323Lys. The second carries the p.Glu1323Lys mutation and a second novel mutation, p.Met1394Arg. Functional studies of both novel alleles showed reduced or null cell surface expression, typical of recessive mutations. Compound heterozygous mutations in congenital hyperinsulinism result in complex interactions. Studying these mechanisms can improve the knowledge of this disease and modify its therapy.",
keywords = "ABCC8, Congenital hyperinsulinism, Functional study, Mutation",
author = "Flavio Faletra and Kara Snider and Show-Ling Shyng and Irene Bruno and Emmanouil Athanasakis and Paolo Gasparini and Carlo Dionisi-Vici and Alessandro Ventura and Qing Zhou and Stanley, {Charles A.} and Alberto Burlina",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.gene.2012.12.055",
language = "English (US)",
volume = "516",
pages = "122--125",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism

T2 - Clinical and functional characterization of two novel ABCC8 mutations

AU - Faletra, Flavio

AU - Snider, Kara

AU - Shyng, Show-Ling

AU - Bruno, Irene

AU - Athanasakis, Emmanouil

AU - Gasparini, Paolo

AU - Dionisi-Vici, Carlo

AU - Ventura, Alessandro

AU - Zhou, Qing

AU - Stanley, Charles A.

AU - Burlina, Alberto

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Congenital hyperinsulinism (CHI) occurs as a consequence of unregulated insulin secretion from the pancreatic beta-cells. Severe recessive mutations and milder dominant mutations have been described in the ABCC8 and KCNJ11 genes encoding SUR1 and Kir6.2 subunits of the beta-cell ATP-sensitive K(+) channel. Here we report two patients with CHI unresponsive to medical therapy with diazoxide. Sequencing analysis identified a compound heterozygous mutation in ABCC8 in both patients. The first one is a carrier for the known mild dominant mutation p.Glu1506Lys jointly with the novel mutation p.Glu1323Lys. The second carries the p.Glu1323Lys mutation and a second novel mutation, p.Met1394Arg. Functional studies of both novel alleles showed reduced or null cell surface expression, typical of recessive mutations. Compound heterozygous mutations in congenital hyperinsulinism result in complex interactions. Studying these mechanisms can improve the knowledge of this disease and modify its therapy.

AB - Congenital hyperinsulinism (CHI) occurs as a consequence of unregulated insulin secretion from the pancreatic beta-cells. Severe recessive mutations and milder dominant mutations have been described in the ABCC8 and KCNJ11 genes encoding SUR1 and Kir6.2 subunits of the beta-cell ATP-sensitive K(+) channel. Here we report two patients with CHI unresponsive to medical therapy with diazoxide. Sequencing analysis identified a compound heterozygous mutation in ABCC8 in both patients. The first one is a carrier for the known mild dominant mutation p.Glu1506Lys jointly with the novel mutation p.Glu1323Lys. The second carries the p.Glu1323Lys mutation and a second novel mutation, p.Met1394Arg. Functional studies of both novel alleles showed reduced or null cell surface expression, typical of recessive mutations. Compound heterozygous mutations in congenital hyperinsulinism result in complex interactions. Studying these mechanisms can improve the knowledge of this disease and modify its therapy.

KW - ABCC8

KW - Congenital hyperinsulinism

KW - Functional study

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=84873099173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873099173&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2012.12.055

DO - 10.1016/j.gene.2012.12.055

M3 - Article

C2 - 23266803

AN - SCOPUS:84873099173

VL - 516

SP - 122

EP - 125

JO - Gene

JF - Gene

SN - 0378-1119

IS - 1

ER -